Donald Tang
Vermögen: 17 226 $ am 30.06.2026
Vermögen: 17 226 $ am 30.06.2026
Donald Tang is the founder of Y11 Sport & Media Ltd., founded in 2017, and Celadon Partners (Asia Pacific) Ltd., founded in 2018, where the title held is Managing Partner.
Current jobs include Independent Director at Senti Biosciences Holdings, Inc. starting in 2026, Director at Senti Biosciences, Inc. starting in 2024, Managing Partner at Celadon Partners LLC, Member at Aspen Global Leadership Network, and Member at Mossavar-Rahmani Center For Business & Government.
Former jobs include Chief Executive Officer at D.
E.
Shaw & Co., (Asia Pacific) Ltd. from 2004 to 2017, Independent Director at Vicarious Surgical, Inc. from 2021 to 2025, and President & Director at D8 Holdings Corp.
from 2020 to 2021.
Education includes undergraduate studies at Carnegie Mellon University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,03 % | 27.03.2026 | 10.368 ( 0,03 % ) | 11 405 $ | 30.06.2026 |
| 26.08.2025 | 40.425 ( 0,62 % ) | 5 821 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Celadon Partners (Asia Pacific) Ltd. | Gründer | 01.01.2018 |
Mossavar-Rahmani Center For Business & Government | Corporate Officer/Principal | - |
Aspen Global Leadership Network | Corporate Officer/Principal | - |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Direktor/Vorstandsmitglied | 02.12.2024 |
Celadon Partners LLC /Private Equity/
Celadon Partners LLC /Private Equity/ Investment ManagersFinance Celadon Partners invests in middle-market companies located across the globe. The firm focuses on a broad range of sectors and industries. It participates in buyout capital requirements. | Private Equity Investor | - |
| Unternehmen | Position | Ende |
|---|---|---|
| VICARIOUS SURGICAL INC. | Direktor/Vorstandsmitglied | 12.09.2025 |
| D8 HLDG | Präsident | 01.01.2021 |
D. E. Shaw & Co., (Asia Pacific) Ltd.
D. E. Shaw & Co., (Asia Pacific) Ltd. Investment ManagersFinance D E Shaw-Asia Pacific is an active, research-oriented manager which utilizes quantitative and qualitative techniques to identify and create investment opportunities which form the basis for their funds and investment vehicles. Quantitative techniques are a central focus of the firm's activities, and are used to identify underpriced and overpriced securities, to manage various forms of portfolio risk and to reduce the cost of transacting in various financial instruments. Their qualitative strategies are based on the detailed analysis of particular companies, resources, industries, economies, and entrepreneurial opportunities. Investments include both publicly traded and privately held financial instruments, certain physical commodities and commercial rights, and in some cases, entire companies. They also provide individually tailored debt and equity financing to both healthy and financially distressed companies and make venture capital investments in early- and later-stage ventures. D. E. Shaw group engages in various forms of private equity investing, acquiring either minority or controlling interests in early-stage and established companies. The firm has special expertise within the energy sector, and engages in activities ranging from the trading of various energy-related commodities and financial instruments to the purchase of ownership positions in power plants and other physical assets. | Corporate Officer/Principal | 31.12.2017 |
Y11 Sport & Media Ltd.
Y11 Sport & Media Ltd. Financial ConglomeratesFinance Operates as a sports investment firm | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
D. E. Shaw & Co., (Asia Pacific) Ltd.
D. E. Shaw & Co., (Asia Pacific) Ltd. Investment ManagersFinance D E Shaw-Asia Pacific is an active, research-oriented manager which utilizes quantitative and qualitative techniques to identify and create investment opportunities which form the basis for their funds and investment vehicles. Quantitative techniques are a central focus of the firm's activities, and are used to identify underpriced and overpriced securities, to manage various forms of portfolio risk and to reduce the cost of transacting in various financial instruments. Their qualitative strategies are based on the detailed analysis of particular companies, resources, industries, economies, and entrepreneurial opportunities. Investments include both publicly traded and privately held financial instruments, certain physical commodities and commercial rights, and in some cases, entire companies. They also provide individually tailored debt and equity financing to both healthy and financially distressed companies and make venture capital investments in early- and later-stage ventures. D. E. Shaw group engages in various forms of private equity investing, acquiring either minority or controlling interests in early-stage and established companies. The firm has special expertise within the energy sector, and engages in activities ranging from the trading of various energy-related commodities and financial instruments to the purchase of ownership positions in power plants and other physical assets. | Finance |
Aspen Global Leadership Network | |
Y11 Sport & Media Ltd.
Y11 Sport & Media Ltd. Financial ConglomeratesFinance Operates as a sports investment firm | Finance |
D8 Holdings Corp.
D8 Holdings Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Celadon Partners (Asia Pacific) Ltd. | |
Mossavar-Rahmani Center For Business & Government | |
Vicarious Surgical, Inc.
Vicarious Surgical, Inc. Medical SpecialtiesHealth Technology Develops surgical robotic systems that enables surgeons to perform minimally invasive surgeries | Health Technology |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
Celadon Partners LLC /Private Equity/
Celadon Partners LLC /Private Equity/ Investment ManagersFinance Celadon Partners invests in middle-market companies located across the globe. The firm focuses on a broad range of sectors and industries. It participates in buyout capital requirements. | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen